Question 1

Does Capula Management own BBIO stock?

Accepted Answer

No. Capula Management exited its BBIO (Bridgebio Pharma) position in Q4 2024. Its Q3 2024 13F listed 32,671 shares worth $831,803.

Question 2

How many shares of BBIO does Capula Management own?

Accepted Answer

None since Q4 2024, when Capula Management exited the position. Its Q3 2024 13F listed 32,671 shares worth $831,803.

Question 3

What is Capula Management's BBIO position worth?

Accepted Answer

Capula Management's BBIO position was worth $831,803 in its Q3 2024 13F, before the exit in Q4 2024.

Question 4

Is Capula Management buying or selling BBIO?

Accepted Answer

In Q4 2024, Capula Management exited its entire BBIO position.

Question 5

When did Capula Management first buy BBIO?

Accepted Answer

Capula Management first reported BBIO in its Q3 2021 13F and listed it in 2 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$27.44	0
2024-Q3	New	32,671	—	$831,803	0.0%	$25.46	34